Connect Biopharma Holdings Ltd
NASDAQ:CNTB
Connect Biopharma Holdings Ltd
NASDAQ:CNTB
Price:
2.6
USD
5.26%
Market Closed
Market Cap:
$145.3m
Balance Sheet
Balance Sheet Decomposition
Connect Biopharma Holdings Ltd
Connect Biopharma Holdings Ltd
Balance Sheet Decomposition is not available for
Connect Biopharma Holdings Ltd
Connect Biopharma Holdings Ltd
Balance Sheet
Connect Biopharma Holdings Ltd
Connect Biopharma Holdings Ltd
Currency: CNY
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
402
|
309
|
1 010
|
1 707
|
550
|
106
|
|
| Cash |
395
|
303
|
976
|
1 646
|
353
|
11
|
|
| Cash Equivalents |
7
|
6
|
34
|
61
|
197
|
95
|
|
| Short-Term Investments |
28
|
31
|
13
|
0
|
511
|
13
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
16
|
23
|
34
|
47
|
23
|
2
|
|
| Total Current Assets |
446
|
363
|
1 057
|
1 754
|
1 085
|
121
|
|
| PP&E Net |
3
|
3
|
8
|
82
|
59
|
5
|
|
| PP&E Gross |
3
|
3
|
8
|
82
|
59
|
5
|
|
| Accumulated Depreciation |
1
|
2
|
3
|
8
|
15
|
3
|
|
| Intangible Assets |
0
|
0
|
0
|
1
|
1
|
0
|
|
| Note Receivable |
5
|
6
|
10
|
18
|
1
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
66
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
10
|
1
|
1
|
0
|
|
| Total Assets |
454
N/A
|
373
-18%
|
1 085
+191%
|
1 856
+71%
|
1 212
-35%
|
126
-90%
|
|
| Liabilities | |||||||
| Accounts Payable |
3
|
23
|
25
|
81
|
83
|
8
|
|
| Accrued Liabilities |
3
|
4
|
12
|
14
|
21
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1
|
1
|
1
|
0
|
|
| Other Current Liabilities |
0
|
0
|
1
|
19
|
4
|
14
|
|
| Total Current Liabilities |
6
|
27
|
38
|
115
|
109
|
24
|
|
| Long-Term Debt |
574
|
644
|
2 072
|
0
|
2
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
5
|
5
|
0
|
|
| Total Liabilities |
581
N/A
|
671
+16%
|
2 110
+214%
|
120
-94%
|
115
-4%
|
25
-78%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
123
|
288
|
1 065
|
2 316
|
3 068
|
520
|
|
| Additional Paid In Capital |
38
|
38
|
42
|
4 094
|
4 095
|
629
|
|
| Treasury Stock |
0
|
0
|
0
|
1
|
1
|
0
|
|
| Other Equity |
42
|
49
|
2
|
41
|
71
|
8
|
|
| Total Equity |
127
N/A
|
298
-135%
|
1 025
-244%
|
1 736
N/A
|
1 097
-37%
|
101
-91%
|
|
| Total Liabilities & Equity |
454
N/A
|
373
-18%
|
1 085
+191%
|
1 856
+71%
|
1 212
-35%
|
126
-90%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
56
|
56
|
56
|
58
|
57
|
55
|
|
Switch to:
Switch to:
See Also
Discover More
